CN108602817B - 二肽基肽酶-iv抑制剂的苯甲酸盐的晶型 - Google Patents
二肽基肽酶-iv抑制剂的苯甲酸盐的晶型 Download PDFInfo
- Publication number
- CN108602817B CN108602817B CN201680075097.XA CN201680075097A CN108602817B CN 108602817 B CN108602817 B CN 108602817B CN 201680075097 A CN201680075097 A CN 201680075097A CN 108602817 B CN108602817 B CN 108602817B
- Authority
- CN
- China
- Prior art keywords
- compound
- benzoate
- methyl
- formula
- crystal form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (14)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510990347 | 2015-12-24 | ||
CN201510990347X | 2015-12-24 | ||
PCT/CN2016/111445 WO2017107945A1 (zh) | 2015-12-24 | 2016-12-22 | 二肽基肽酶-iv抑制剂的苯甲酸盐的晶型 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108602817A CN108602817A (zh) | 2018-09-28 |
CN108602817B true CN108602817B (zh) | 2020-12-25 |
Family
ID=59089113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201680075097.XA Active CN108602817B (zh) | 2015-12-24 | 2016-12-22 | 二肽基肽酶-iv抑制剂的苯甲酸盐的晶型 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN108602817B (zh) |
WO (1) | WO2017107945A1 (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102127072A (zh) * | 2010-01-15 | 2011-07-20 | 山东轩竹医药科技有限公司 | 吡啶并环衍生物 |
CN102863440A (zh) * | 2011-07-09 | 2013-01-09 | 山东轩竹医药科技有限公司 | 二肽基肽酶-iv抑制剂的盐的晶型 |
WO2013046229A1 (en) * | 2011-09-26 | 2013-04-04 | Hetero Research Foundation | Novel salts of alogliptin |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8324383B2 (en) * | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
-
2016
- 2016-12-22 WO PCT/CN2016/111445 patent/WO2017107945A1/zh active Application Filing
- 2016-12-22 CN CN201680075097.XA patent/CN108602817B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102127072A (zh) * | 2010-01-15 | 2011-07-20 | 山东轩竹医药科技有限公司 | 吡啶并环衍生物 |
WO2011085643A1 (zh) * | 2010-01-15 | 2011-07-21 | 山东轩竹医药科技有限公司 | 吡啶并环衍生物 |
CN102863440A (zh) * | 2011-07-09 | 2013-01-09 | 山东轩竹医药科技有限公司 | 二肽基肽酶-iv抑制剂的盐的晶型 |
WO2013046229A1 (en) * | 2011-09-26 | 2013-04-04 | Hetero Research Foundation | Novel salts of alogliptin |
Also Published As
Publication number | Publication date |
---|---|
WO2017107945A1 (zh) | 2017-06-29 |
CN108602817A (zh) | 2018-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3453708A1 (en) | Process for the preparation of 5-chloro-n-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n-2-(isopropylsulfonyl)phenyl)-2,4-diamine di-hydrochloride | |
US10160759B2 (en) | Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor | |
RU2577334C2 (ru) | КРИСТАЛЛИЧЕСКАЯ ФОРМА МОНОГИДРАТА ГИДРОХЛОРИДА (R)-7-ХЛОР-N-(ХИНУКЛИДИН-3-ИЛ)БЕНЗО[b]ТИОФЕН-2-КАРБОКСАМИДА | |
JP7374496B2 (ja) | Bcl-2タンパク質を阻害するためのN-ベンゼンスルホニルベンズアミド系化合物、その組成物および使用 | |
TW200838512A (en) | Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof | |
AU2018251119A1 (en) | Opioid receptor (MOR) agonist salt, fumarate salt I crystal form thereof and preparation method thereof | |
TWI745289B (zh) | 一種週期素依賴性蛋白激酶抑制劑的結晶形式及其製備方法 | |
WO2011023146A1 (en) | Imatinib mesylate polymorphs generated by crystallization in aqueous inorganic salt solutions | |
US9884856B2 (en) | Crystal form of Dabrafenib mesylate and preparation method thereof | |
CN104803971B (zh) | 化合物A单苯甲酸盐的晶型α及其制备方法和含有该晶型的药物组合物 | |
CN108884099B (zh) | 一种咪唑并异吲哚类衍生物的游离碱的结晶形式及其制备方法 | |
CN106349215B (zh) | 一种化合物a苯甲酸盐的无定形及其制备方法和含有该无定形的药物组合物 | |
CN108602817B (zh) | 二肽基肽酶-iv抑制剂的苯甲酸盐的晶型 | |
JP6785523B2 (ja) | ナトリウム−グルコース共輸送体2阻害剤の結晶形 | |
AU2016269359A1 (en) | Sodium salt of uric acid transporter inhibitor and crystalline form thereof | |
CN106349216B (zh) | 化合物A的晶型α及其制备方法和含有该晶型的药物组合物 | |
EP4089085B1 (en) | Manufacturing and purification method of polycrystalline form of dehydrophenylahistin-like compound | |
JP6761564B2 (ja) | ナトリウム・グルコース共輸送体2阻害薬のl−プロリン化合物、およびl−プロリン化合物の一水和物および結晶 | |
CN109219607B (zh) | 二肽基肽酶-iv抑制剂的丁二酸盐的晶型 | |
CN113045554A (zh) | 一种非索替尼晶型及其制备方法 | |
KR20200024302A (ko) | 페닐 피리미돈 화합물의 염, 다형체 및 이의 약학 조성물 및 용도 | |
KR102467444B1 (ko) | 이소-엑시구아민 A(iso-exiguamine A) 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 IDO-1 관련 질환의 예방 또는 치료용 약학적 조성물 | |
CN113493435A (zh) | 一种化合物a苯甲酸盐的无定形及其制备方法和含有该无定形的药物组合物 | |
JP2022524011A (ja) | 化合物結晶形、その製造方法、医薬組成物及び使用 | |
EP3677581A1 (en) | Deuterated indoleamine 2,3-dioxygenase inhibitor and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20191022 Address after: Room 510, building 2, No. 88, Kechuang 6th Street, Beijing Economic and Technological Development Zone, Beijing 100176 Applicant after: Xuanzhu (Beijing) Pharmaceutical Technology Co.,Ltd. Address before: High tech Zone Tianchen road Ji'nan City, Shandong province 250101 No. 2518 Applicant before: XUANZHU PHARMA Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200928 Address after: 135000 No. 666, Kangmei Avenue, Meihekou City, Tonghua City, Jilin Province Applicant after: Jilin Huisheng biopharmaceutical Co.,Ltd. Applicant after: Beijing huizhiheng Biotechnology Co.,Ltd. Address before: Room 510, building 2, No. 88, Kechuang 6th Street, Beijing Economic and Technological Development Zone, Beijing 100176 Applicant before: Xuanzhu (Beijing) Pharmaceutical Technology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 135007 No. 666, Kangmei Avenue, Meihekou City, Tonghua City, Jilin Province Patentee after: Jilin Huisheng Biopharmaceutical Co.,Ltd. Patentee after: Beijing huizhiheng Biotechnology Co.,Ltd. Address before: NO.666 Kangmei Avenue, Meihekou City, Tonghua City, Jilin Province Patentee before: Jilin Huisheng biopharmaceutical Co.,Ltd. Patentee before: Beijing huizhiheng Biotechnology Co.,Ltd. |
|
CP03 | Change of name, title or address |